Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

RDF description of Ibrutinib holds promise for patients with 17p deletion CLL - http://irises.unisr.it/resource/item/34008
rights: termsOfUse
date: 2026-08-24T09:28:47
publisher: Ibrutinib holds promise for patients with 17p deletion CLL
type: Document

Generically Dependent Continuant
type: Class

Article
type: Class

1403471
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Ibrutinib holds promise for patients with 17p deletion CLL

Ibrutinib holds promise for patients with 17p deletion CLL
type: Document
type: Article
type: Generically Dependent Continuant
type: Academic Article
type: Thing
language: Inglese
type: Continuant
type: Information Content Entity
type: Entity
related by: 1403471
most specific type: Academic Article

Inglese
type: Language

Information Content Entity
type: Class